Healthcare -
Biotechnology - NASDAQ - US
$ 7.83
0.643 %
$ 1.23 B
Market Cap
-6.07
P/E
OCUL - GROSS PROFIT
Gross Profit OCUL - Ocular Therapeutix, Inc.
53.2 M
LAST VALUE
16.58%
2 YEAR CAGR
103.45%
5 YEAR CAGR
21.58%
10 YEAR CAGR